A pooled SPYRAL HTN analysis (n = 2,137) showed sustained blood pressure reductions through 3 years after Symplicity Spyral renal denervation. A separate pooled analysis found a 42% reduction in ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...

Route 92 Medical, Inc. announced the commencement of the SUMMIT RISE postmarket study evaluating the performance of the company&rs ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

Salus Scientific Corporation, a developer of radiation protection garments and clinical workflow solutions for fluoroscopy-guided ...

VentureMed Group, Inc. announced it is now doing business as (DBA) Flex Vascular. The medical device company specializes in ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

A clinical discussion on how the long-term findings of the ZILVERPASS study inform decision-making for challenging ...

Assuming that there is a proper indication for IVC filter placement, the procedure is performed using sterile technique. In some instances, IVC filter placement has been performed using intravascular ...